Healthcare Provider Outreach Education
Offers providers and prescribers education through evidence-based information to support therapeutic decisions specific to pain management and substance use disorder to optimize clinical decisions and improve patient care. The goals of this pilot include: Improving opioid prescribing practices, increase clinician use of the PDMP, prevent overdose and prevent rampant access and reduce youth and adult access to prescription medication for non-medical purposes deaths. Program Coordinator: Janet Canar - [email protected] or 410-313-3568
- Mentoring, training and education for providers
- Resources for treating Opioid Use Disorder
- Provider support for Medications for Addiction Treatment (MAT) waiver. To learn more about the MAT waiver, click HERE.
Prescription Drug Monitoring Program (PDMP)
The Maryland Prescription Drug Monitoring Program (PDMP) was created to support providers and their patients with the safe and effective use of prescription drugs. The PDMP is part of Maryland's response to the ongoing opioid epidemic in Maryland and across the country.
Beginning October 1, 2016, practitioners authorized to prescribe Controlled Dangerous Substances (CDS) in Maryland must be registered with the PDMP prior to obtaining a new or renewal State CDS Registration by July 1, 2017, whichever occurs sooner. This applies to physicians, physicians assistants, nurse practitioners, nurse midwives, dentists, podiatrists and veterinarians. This mandate does not apply to nurses.
For more information, visit the Maryland Prescription Drug Monitoring page.